Terns Pharmaceuticals, Inc. (TERN)
37.02
+0.44
(+1.20%)
USD |
NASDAQ |
Jan 21, 14:43
Terns Pharmaceuticals Free Cash Flow: -77.99M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Altimmune, Inc. | -66.66M |
| Ligand Pharmaceuticals, Inc. | 20.43M |
| ADMA Biologics, Inc. | 40.61M |
| Viking Therapeutics, Inc. | -224.58M |
| Cidara Therapeutics, Inc. | -132.94M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -19.77M |
| Cash from Investing (Quarterly) | 24.50M |
| Free Cash Flow Per Share (Quarterly) | -0.2156 |
| Free Cash Flow to Equity (Quarterly) | -19.67M |
| Free Cash Flow to Firm (Quarterly) | -19.77M |
| Free Cash Flow Yield | -2.30% |